Israel excels in Burkitt's lymphoma treatment, with Sourasky Medical Center (Ichilov), Rambam Medical Center, and Hadassah Medical Center at the forefront. Sourasky, accredited by the Joint Commission International, achieves a 90% success rate in oncology. Rambam, also accredited, features Nobel Prize-winning specialists. Hadassah is renowned for oncology excellence, serving a global patient base.
Innovative treatments like CAR T-cell therapy, monoclonal antibody therapy, stem cell transplantation, and targeted therapy are available. Israel's high survival rates are attributed to these advanced therapies and expert medical professionals. For detailed statistics, refer to this study.